Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in ALKS — Alkermes plc.

CIK 902219 Boston, MA

Position in ALKS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$105,025,067
+$20,513,104 QoQ
Shares Held
2,970,166
-1.7% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 58.61224591487479.ToString("F0")% None 41.38775408512521.ToString("F0")%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $3,311,744,758 across 31 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ALKS
Alkermes plc.
This page
2,970,166 $105,025,067

All Filings in ALKS

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $105,025,067 2,970,166
2025-12-31 $84,511,963 3,020,442
2025-09-30 $11,255,700 375,190
2025-06-30 $48,639,943 1,700,103
2025-03-31 $102,258,941 3,096,879
2024-12-31 $201,679,008 7,012,483
2024-09-30 $354,304,275 12,658,245
2024-06-30 $345,949,521 14,354,752
2024-03-31 $403,136,180 14,892,360
2023-12-31 $422,798,375 15,241,470
2023-09-30 $329,027,642 11,746,792
2023-06-30 $240,724,103 7,690,866
2023-03-31 $189,164,341 6,710,335
2022-12-31 $157,939,593 6,044,378
2022-09-30 $150,111,300 6,722,405
2022-06-30 $177,400,400 5,955,032
2022-03-31 $302,026,722 11,479,541
2021-12-31 $274,659,243 11,808,222
2021-09-30 $364,165,566 11,808,222
2021-06-30 $348,959,736 14,231,637
2021-03-31 $383,452,370 20,527,429
2020-12-31 $409,731,083 20,537,899
2020-06-30 $425,539,653 21,923,733
2020-03-31 $316,267,829 21,932,582